Castrate Resistant Prostate Cancer Enhertu Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Castrate Resistant Prostate Cancer Enhertu Therapy — Stella

Home/Prostate Cancer Metastatic/

View on ClinicalTrials.gov

Recruiting

Back to Prostate Cancer Metastatic trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Washington DC VAMC, Washington D.C., District of Columbia

Key details

Phase

Safety & dosing

Sponsor

Washington D.C. Veterans Affairs Medical Center

Collaborators

Daiichi Sankyo, Cancer Research And Biostatistics

Enrollment target

~60 participants

Started

March 2025

Primary completion

October 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Sex

Male only

Last updated April 2026